CompanySXTP SXTPWNasdaqWashington, DC

60 Degrees Pharmaceuticals LLC

60 Degrees Pharmaceuticals develops medicines for vector-borne disease.

SEC EDGAR ClinicalTrials.gov 60degreespharma.com

8-KSep 14Latest SEC filing, period to Sep 12

Aug 4Latest story

August 2026

60 Degrees Pharmaceuticals prices $1.0 million private placement

Aug 4Financing60 Degrees Pharmaceuticals LLC